i-Stat CK-MP cartridges Abbott Point of Care Inc. The i-Stat CKMB test is an in vitro diagnostic test for the quantitative measurement of creatinine kinase MB mass in whole blood or plasma samples. CK-MB measurements can be used as an aid in the diagnosis and treatment of myocardial infarction (MI).
Published August 15, 2012 · Recall initiated: February 1, 2012
Summary
FDA records medical device Class II recall Z-2171-2012, published August 15, 2012 and initiated February 1, 2012. Recalling firm: Abbott Point Of Care Inc.; Status: Terminated; Reported quantity: 368,149 cartridges US; 32,725 OUS; Lot: List number 06F25-01, 06F25-02, 03P92-25, All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Point Of Care Inc.
- Distributor
- Worldwide Distribution - USA including AZ and CO and internationally to Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Chile, China, Colombia, Costa Rica, Dominican Republic, El Salvador, Finland, France, Georgia, Germany, Greece, Honduras, Hong Kong, India, Ireland, Italy, Korea, Kuwait, Mauritius, Mexico, Netherland (Antilles), Nigeria, Norway, Oman, Paraguay, Peru, Poland, Portugal, Qatar, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, R.O.C., Thailand, UAE, United Kingdom, and Yemen.
- Lot
- List number 06F25-01, 06F25-02, 03P92-25, All lots
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAi-STAT EG6+ cartridge; List Number: 03P77-25;May 6, 2026
- FDAi-STAT G3+ cartridge; List Number: 03P78-26;May 6, 2026
- FDAi-STAT EG7+ cartridge; List Number: 03P76-25;May 6, 2026
- FDAi-STAT EG6+ cartridge. List Number: 03P77-25.September 24, 2025
- FDAi-Stat BNP cartridges Abbott Point of Care Inc. The i-Stat BNP test is an in vitro diagnostic test for theAugust 15, 2012
- FDAEasyLink(TM) Informatics System, Part Number 1000034805. EasyLink(TM) Informatics System is classified as aAugust 15, 2012
Questions about this recall
Was i-Stat CK-MP cartridges Abbott Point of Care Inc. The i-Stat CKMB test is an in vitro diagnostic test for the quantitative measurement of creatinine kinase MB mass in whole blood or plasma samples. CK-MB measurements can be used as an aid in the diagnosis and treatment of myocardial infarction (MI). recalled?
Yes. FDA published recall Z-2171-2012 on August 15, 2012. Reported hazard: The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.
What should I do if I have this product?
Voluntary: Firm initiated · Letter